2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO36] Mini-Oral Session 36　Palliative Care / Symptom Management 2

Sat. Feb 19, 2022 3:40 PM - 4:30 PM Room 6 (Room D, 1F, Kyoto International Conference Center)

Chair：Toshiyuki Sawa（Cancer Center, Gifu Municipal Hospital），Takuo Shibayama（Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center）

[MO36-2] Phase 3 safety study of fosnetupitant for prevention of chemotherapy-induced nausea and vomiting with AC/EC regimen

○Kenichi Inoue1, Kazuo Matsuura2, Junji Tsurutani3, Yuko Tanabe4, Tetsuhiko Taira5, Kaoru Kubota6, Tomohide Tamura7, Toshiaki Saeki2 (1.Division of Breast Oncology, Saitama Cancer Center, 2.Department of Breast Oncology, Saitama Medical University International Medical Center., 3.Advanced Cancer Translational Research Institute, Showa University, 4.Department of Medical Oncology, Toranomon Hospital, 5.Department of Medical Oncology, Sagara Hospital, 6.Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, 7.Thoracic Center, St. Luke's International Hospital)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password